• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尽管已确认清除严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒,但基础疾病仍与新冠病毒疾病(COVID-19)患者的住院治疗有关。

Pre-existing conditions are associated with COVID-19 patients' hospitalization, despite confirmed clearance of SARS-CoV-2 virus.

作者信息

Pawlowski Colin, Venkatakrishnan A J, Ramudu Eshwan, Kirkup Christian, Puranik Arjun, Kayal Nikhil, Berner Gabriela, Anand Akash, Barve Rakesh, O'Horo John C, Badley Andrew D, Soundararajan Venky

机构信息

nference, One Main Street, Cambridge, MA 02142, United States.

nference Labs, Indiqube, 22, 3rd Cross Rd, S R Layout, Murgesh Pallya, Bengaluru, Karnataka 560017, India.

出版信息

EClinicalMedicine. 2021 Apr;34:100793. doi: 10.1016/j.eclinm.2021.100793. Epub 2021 Mar 23.

DOI:10.1016/j.eclinm.2021.100793
PMID:33778434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7985595/
Abstract

BACKGROUND

Consecutive negative SARS-CoV-2 PCR test results are being considered to estimate viral clearance in COVID-19 patients. However, there are anecdotal reports of hospitalization from protracted COVID-19 complications despite such confirmed viral clearance, presenting a clinical conundrum.

METHODS

We conducted a retrospective analysis of 222 hospitalized COVID-19 patients to compare those that were readmitted post-viral clearance ( = 49) with those that were not re-admitted post-viral clearance ( = 173) between February and October 2020. In order to differentiate these two cohorts, we used neural network models for the 'augmented curation' of comorbidities and complications with positive sentiment in the Electronic Hosptial Records physician notes.

FINDINGS

In the year preceding COVID-19 onset, anemia ( = 13 [26.5%], p-value: 0.007), cardiac arrhythmias ( = 14 [28.6%], p-value: 0.015), and acute kidney injury ( = 7 [14.3%], p-value: 0.030) were significantly enriched in the physician notes of the .

INTERPRETATION

Overall, this retrospective study highlights specific pre-existing conditions that are associated with higher hospitalization rates in COVID-19 patients despite viral clearance and motivates follow-up prospective research into the associated risk factors.

FUNDING

This work was supported by Nference, inc.

摘要

背景

连续的新冠病毒2型(SARS-CoV-2)聚合酶链反应(PCR)检测阴性结果被用于评估新冠肺炎患者的病毒清除情况。然而,有轶事报道称,尽管已确认病毒清除,但仍有新冠肺炎患者因长期并发症而住院,这带来了一个临床难题。

方法

我们对222例住院的新冠肺炎患者进行了回顾性分析,以比较2020年2月至10月期间病毒清除后再次入院的患者(n = 49)和病毒清除后未再次入院的患者(n = 173)。为了区分这两个队列,我们使用神经网络模型对电子病历医生记录中具有积极情绪的合并症和并发症进行“增强整理”。

研究结果

在新冠肺炎发病前一年,贫血(n = 13 [26.5%],p值:0.007)、心律失常(n = 14 [28.6%],p值:0.015)和急性肾损伤(n = 7 [14.3%],p值:0.030)在……的医生记录中显著富集。

解读

总体而言,这项回顾性研究突出了特定的既往疾病,这些疾病与新冠肺炎患者在病毒清除后较高的住院率相关,并促使对相关风险因素进行后续的前瞻性研究。

资金支持

这项工作得到了Nference公司的支持。

相似文献

1
Pre-existing conditions are associated with COVID-19 patients' hospitalization, despite confirmed clearance of SARS-CoV-2 virus.尽管已确认清除严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒,但基础疾病仍与新冠病毒疾病(COVID-19)患者的住院治疗有关。
EClinicalMedicine. 2021 Apr;34:100793. doi: 10.1016/j.eclinm.2021.100793. Epub 2021 Mar 23.
2
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
3
A Prospective Study on Risk Factors for Acute Kidney Injury and All-Cause Mortality in Hospitalized COVID-19 Patients From Tehran (Iran).一项关于德黑兰(伊朗)住院 COVID-19 患者急性肾损伤和全因死亡率的危险因素的前瞻性研究。
Front Immunol. 2022 Jul 8;13:874426. doi: 10.3389/fimmu.2022.874426. eCollection 2022.
4
Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection.长新冠脑雾和肌肉疼痛与急性感染期间上呼吸道 SARS-CoV-2 RNA 清除时间延长有关。
Front Immunol. 2023 Apr 28;14:1147549. doi: 10.3389/fimmu.2023.1147549. eCollection 2023.
5
Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study.中国武汉 116 例 COVID-19 住院患者的临床特征:一项以医院为中心、回顾性、观察性研究。
BMC Infect Dis. 2020 Oct 22;20(1):787. doi: 10.1186/s12879-020-05452-2.
6
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗(灭活,Vero 细胞)有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
7
Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.SARS-CoV-2 感染后 2 年住院与非住院患者的新冠后症状。
JAMA Netw Open. 2022 Nov 1;5(11):e2242106. doi: 10.1001/jamanetworkopen.2022.42106.
8
Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.挪威 2019 年冠状病毒病(NO COVID-19)实用开放性标签研究,评估硫酸羟氯喹在 2019 年冠状病毒病中度重症住院患者中的早期使用:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 5;21(1):485. doi: 10.1186/s13063-020-04420-0.
9
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区,5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
10
Re-positive testing, clinical evolution and clearance of infection: results from COVID-19 cases in isolation in Viet Nam.再次检测阳性、临床演变和感染清除:越南隔离 COVID-19 病例的结果。
Western Pac Surveill Response J. 2021 Dec 13;12(4):1-11. doi: 10.5365/wpsar.2021.12.4.857. eCollection 2021 Oct-Dec.

引用本文的文献

1
A multinational cross-sectional study on the prevalence and predictors of long COVID across 33 countries.一项关于33个国家中长新冠的患病率及预测因素的跨国横断面研究。
Sci Rep. 2025 Aug 3;15(1):28299. doi: 10.1038/s41598-025-10120-z.
2
Effectiveness of azvudine versus nirmatrelvir/ritonavir for hospitalized patients with SARS-CoV-2 infection and pre-existing liver diseases.阿兹夫定与奈玛特韦/利托那韦治疗合并基础肝病的新型冠状病毒肺炎住院患者的疗效比较
Virol J. 2025 May 19;22(1):147. doi: 10.1186/s12985-025-02771-1.
3
"I'm in Hell …": Experiences of Unmet Health Care Needs Among People with Pre-Existing Disability and Long COVID.

本文引用的文献

1
Mapping each pre-existing condition's association to short-term and long-term COVID-19 complications.将每种既往疾病与新冠病毒疾病短期和长期并发症的关联进行映射分析。
NPJ Digit Med. 2021 Jul 27;4(1):117. doi: 10.1038/s41746-021-00484-7.
2
Acute Kidney Injury in Hospitalized Patients Infected with COVID-19 from Wuhan, China: A Retrospective Study.中国武汉 COVID-19 住院患者的急性肾损伤:一项回顾性研究。
Biomed Res Int. 2021 Jan 11;2021:6655185. doi: 10.1155/2021/6655185. eCollection 2021.
3
COVID-19 in Immunocompromised Hosts: What We Know So Far.
“我身处地狱……”:残疾老人和新冠长期症状患者未满足的医疗需求体验
J Health Care Poor Underserved. 2025;36(2):572-589. doi: 10.1353/hpu.2025.a959114.
4
Identification and Characterization of Immune Checkpoint Inhibitor-Induced Toxicities From Electronic Health Records Using Natural Language Processing.利用自然语言处理从电子健康记录中识别和描述免疫检查点抑制剂诱导的毒性。
JCO Clin Cancer Inform. 2024 Apr;8:e2300151. doi: 10.1200/CCI.23.00151.
5
Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study.口服阿兹夫定用于患有新冠肺炎及基础疾病的住院患者:一项回顾性队列研究。
EClinicalMedicine. 2023 May 5;59:101981. doi: 10.1016/j.eclinm.2023.101981. eCollection 2023 May.
6
Host-Pathogen Interactions Influencing Zoonotic Spillover Potential and Transmission in Humans.宿主-病原体相互作用影响人类中动物源性病原体溢出的潜力和传播。
Viruses. 2023 Feb 22;15(3):599. doi: 10.3390/v15030599.
7
Preliminary Observations from The FILLED Project (FILipino Lived Experiences during COVID-19).《FILLED 项目(菲律宾人在 COVID-19 期间的生活体验)初步观察》。
Int J Environ Res Public Health. 2022 Sep 28;19(19):12303. doi: 10.3390/ijerph191912303.
8
What might COVID-19 patients experience after recovery? A comprehensive review.新冠病毒感染患者康复后可能会经历什么?一篇综合综述。
Int J Pharm Pract. 2022 Nov 4;30(5):404-413. doi: 10.1093/ijpp/riac026.
9
Characteristics, risk factors, and outcomes associated with readmission in COVID-19 patients: A systematic review and meta-analysis.与 COVID-19 患者再入院相关的特征、风险因素和结局:系统评价和荟萃分析。
Am J Emerg Med. 2022 Feb;52:166-173. doi: 10.1016/j.ajem.2021.12.012. Epub 2021 Dec 11.
10
Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19.Ad26.COV2.S腺病毒载体疫苗预防新型冠状病毒肺炎的有效性分析
JAMA Netw Open. 2021 Nov 1;4(11):e2132540. doi: 10.1001/jamanetworkopen.2021.32540.
免疫功能低下宿主中的 COVID-19:目前我们已知的情况。
Clin Infect Dis. 2021 Jan 27;72(2):340-350. doi: 10.1093/cid/ciaa863.
4
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.新冠肺炎出院患者 6 个月的后果:一项队列研究。
Lancet. 2021 Jan 16;397(10270):220-232. doi: 10.1016/S0140-6736(20)32656-8. Epub 2021 Jan 8.
5
Clinical characteristics of recovered COVID-19 patients with re-detectable positive RNA test.新冠病毒核酸检测复阳康复患者的临床特征
Ann Transl Med. 2020 Sep;8(17):1084. doi: 10.21037/atm-20-5602.
6
COVID-19 reinfection in a healthcare worker.一名医护人员感染新冠病毒后再次感染
J Med Virol. 2021 Jul;93(7):4058-4059. doi: 10.1002/jmv.26565. Epub 2021 Feb 15.
7
Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study.中国武汉 COVID-19 幸存者的临床后遗症:一项单中心纵向研究。
Clin Microbiol Infect. 2021 Jan;27(1):89-95. doi: 10.1016/j.cmi.2020.09.023. Epub 2020 Sep 23.
8
Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC).从纵向实验室检测推断 COVID-19 相关凝血障碍 (CAC) 的时间演变。
Elife. 2020 Aug 17;9:e59209. doi: 10.7554/eLife.59209.
9
Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis.从庞大的电子健康记录系统中增强对临床记录的注释可揭示即将出现 COVID-19 诊断的症状。
Elife. 2020 Jul 7;9:e58227. doi: 10.7554/eLife.58227.
10
Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?新冠康复后临床复发的 COVID-19 症状:病毒复发、再感染还是炎症反弹?
J Infect. 2020 Nov;81(5):816-846. doi: 10.1016/j.jinf.2020.06.073. Epub 2020 Jun 30.